...
机译:CDKN1A介导的MLL-AF4阳性急性淋巴细胞白血病对极光激酶-A抑制剂的反应性
Division of Hematology/Oncology Department of Internal Medicine National Cheng Kung University;
Department of Pharmacology National Cheng Kung University Tainan Taiwan;
Department of Pediatrics National Cheng Kung University Hospital Tainan Taiwan;
Eppley Institute for Research in Cancer and Allied Diseases University of Nebraska Medical Center;
Institute of Biotechnology and Pharmaceutical Research National Health Research Institutes Miaoli;
National Institute of Cancer Research National Health Research Institutes Tainan Taiwan;
Institute of Bioinformatics and Biosignal Transduction National Cheng Kung University Tainan;
Department of Pathology National Cheng Kung University Hospital Tainan Taiwan;
Division of Hematology/Oncology Chi-Mei Medical Centre Tainan Liouying Taiwan Department of;
Division of Hematology/Oncology Department of Internal Medicine National Cheng Kung University;
Institute of Bioinformatics and Biosignal Transduction National Cheng Kung University Tainan;
Graduate Institute of Medical Science College of Medicine Taipei Medical University Taipei;
Institute of Bioinformatics and Biosignal Transduction National Cheng Kung University Tainan;
Division of Hematology/Oncology Department of Internal Medicine National Cheng Kung University;
Acute lymphoblastic leukemia; Aurora kinase inhibitors; CDKN1A; MLL-AF4;
机译:CDKN1A介导的MLL-AF4阳性急性淋巴细胞白血病对Aurora激酶-A抑制剂的反应性
机译:年龄相关的白血病生物学和预后差异:MLL-AF4阳性急性淋巴细胞白血病的范例
机译:非婴儿患MLL-AF4阳性的急性淋巴细胞白血病的预后良好:东京儿童癌症研究小组的报告
机译:利用人工神经网络优化急性淋巴细胞白血病和急性髓性白血病样品的分类
机译:培养的人类免疫细胞,培养的人类急性淋巴细胞白血病细胞和急性粒细胞性白血病患者呼气中的挥发性生物标志物
机译:Aurora激酶抑制剂PHA-739358(Danusertib)治疗人B前急性淋巴细胞白血病
机译:CDKN1A介导的MLL-AF4阳性急性淋巴细胞白血病对Aurora激酶-A抑制剂的反应